Doaa A Gamal
Overview
Explore the profile of Doaa A Gamal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
1
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gamal D, Morsy A, Omar M
Oncotarget
. 2025 Feb;
16:67-78.
PMID: 39945465
Background: Anti-epidermal growth factor receptor therapy showed an overall median survival improvement in metastatic colorectal cancer. Maintenance with anti in metastatic colorectal cancer wild type was studied in many trials...
2.
Zahran A, Rayan A, Saad K, Rezk K, Soliman A, Rizk M, et al.
J Clin Med Res
. 2024 Aug;
16(7-8):363-374.
PMID: 39206103
Background: The current study was conducted to explore the impact of macrophages and programmed cell death protein 1 (PD-1) expression on tumor-infiltrating lymphocytes (TILs) on treatment outcomes and to define...
3.
Rayan A, Shahine M, Rezk K, Zahran A, Aboshanif M, Gamal D
Ecancermedicalscience
. 2024 Feb;
17:1611.
PMID: 38414964
Background And Aim: We aimed from the current study to explore the treatment results of cetuximab in combination with a weekly carboplatin and paclitaxel regimen in advanced squamous cell carcinoma...
4.
Youssief A, Gamal D, El-Naggar M, Zarzor M, A R, Ahmed S
Asian Pac J Cancer Prev
. 2022 May;
23(5):1733-1740.
PMID: 35633559
Background: Repopulation of tumor cells during radiotherapy of transitional cell bladder carcinoma is believed to be a significant cause for treatment failure, and it was reported from clinical observations that...
5.
Rayan A, Abdel-Kareem S, Hasan H, Zahran A, Gamal D
Rep Pract Oncol Radiother
. 2020 Sep;
25(6):890-898.
PMID: 32982596
Background And Aim: the study aimed to determine whether hypofractionated radiotherapy (HFRT) with simultaneous and adjuvant temozolomide (TMZ) was feasible and could provide adequate disease control in primary GBM patients...